Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Chervinsky

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Chest|March 20, 1999
Long-term cardiovascular safety of salmeterol powder pharmacotherapy in adolescent and adult patients with chronic persistent asthma: a randomized clinical trialP Chervinsky, P Goldberg, S Galant, et al.
Archives of Internal Medicine|June 13, 1998
Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study GroupT F Reiss, P Chervinsky, R J Dockhorn, et al.
Pulmonary Pharmacology & Therapeutics|November 28, 2015
Roflumilast for asthma: Safety findings from a pooled analysis of ten clinical studiesP Chervinsky, E O Meltzer, W Busse, et al.
American Journal of Respiratory and Critical Care Medicine|October 6, 1997
Efficacy of inhaled fluticasone propionate in asthma results from topical and not from systemic activityM Lawrence, J Wolfe, D R Webb, et al.
The European Respiratory Journal|July 10, 1998
Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study GroupM J Noonan, P Chervinsky, M Brandon, et al.
Pulmonary Pharmacology & Therapeutics|October 27, 2015
Roflumilast for asthma: Efficacy findings in placebo-controlled studiesE O Meltzer, P Chervinsky, W Busse, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 7, 2001
Comparison of powder and aerosol formulations of salmeterol in the treatment of asthmaJ Wolfe, S Kreitzer, P Chervinsky, et al.
The Journal of Allergy and Clinical Immunology|October 1, 1994
Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. The Fluticasone Propionate Asthma Study GroupP Chervinsky, A van As, E A Bronsky, et al.
The Journal of Allergy and Clinical Immunology|January 1, 1984
Concomitant bitolterol mesylate aerosol and theophylline for asthma therapy, with 24 hr electrocardiographic monitoringJ P Kemp, P Chervinsky, H A Orgel, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 27, 1999
Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthmaD S Pearlman, W Stricker, S Weinstein, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Chest|March 20, 1999
Long-term cardiovascular safety of salmeterol powder pharmacotherapy in adolescent and adult patients with chronic persistent asthma: a randomized clinical trialP Chervinsky, P Goldberg, S Galant, et al.
Archives of Internal Medicine|June 13, 1998
Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study GroupT F Reiss, P Chervinsky, R J Dockhorn, et al.
Pulmonary Pharmacology & Therapeutics|November 28, 2015
Roflumilast for asthma: Safety findings from a pooled analysis of ten clinical studiesP Chervinsky, E O Meltzer, W Busse, et al.
American Journal of Respiratory and Critical Care Medicine|October 6, 1997
Efficacy of inhaled fluticasone propionate in asthma results from topical and not from systemic activityM Lawrence, J Wolfe, D R Webb, et al.
The European Respiratory Journal|July 10, 1998
Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study GroupM J Noonan, P Chervinsky, M Brandon, et al.
Pulmonary Pharmacology & Therapeutics|October 27, 2015
Roflumilast for asthma: Efficacy findings in placebo-controlled studiesE O Meltzer, P Chervinsky, W Busse, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 7, 2001
Comparison of powder and aerosol formulations of salmeterol in the treatment of asthmaJ Wolfe, S Kreitzer, P Chervinsky, et al.
The Journal of Allergy and Clinical Immunology|October 1, 1994
Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. The Fluticasone Propionate Asthma Study GroupP Chervinsky, A van As, E A Bronsky, et al.
The Journal of Allergy and Clinical Immunology|January 1, 1984
Concomitant bitolterol mesylate aerosol and theophylline for asthma therapy, with 24 hr electrocardiographic monitoringJ P Kemp, P Chervinsky, H A Orgel, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 27, 1999
Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthmaD S Pearlman, W Stricker, S Weinstein, et al.
Pageof 6